IPG Photonics Corporation — FY2012 Form 10-K
Business context and reporting period. The filing covers the fiscal year ended December 31, 2012; fourth-quarter figures are also disclosed. IPG develops and manufactures fiber lasers, amplifiers, diode lasers and laser systems, primarily for materials processing. It operates globally and is vertically integrated. Materials processing represented 87.5% of FY2012 sales.
Key financial results
| Metric | FY2012 | FY2011 | Change |
|---|---|---|---|
| Net sales | $562.5 million | $474.5 million | +18.6% |
| Gross profit / margin | $304.7 million / 54.2% | $257.3 million / 54.2% | Margin unchanged |
| Operating income / margin | $208.9 million / 37.1% | $175.5 million / 37.0% | +19.0% income |
| Net income attributable to IPG | $145.0 million | $117.8 million | +23.1% |
| Diluted EPS | $2.81 | $2.41 | +16.6% |
| Cash from operating activities | $175.3 million | $87.4 million | +$87.9 million |
| Capital expenditures | $68.2 million | $53.0 million | +$15.2 million |
Fourth quarter: Sales were $145.0 million versus $123.5 million in Q4 2011; gross profit was $75.2 million versus $66.4 million; net income attributable to IPG was $34.9 million versus $31.1 million; diluted EPS was $0.67 versus $0.64.
Liquidity and debt at year-end: Cash and cash equivalents were $384.1 million, up from $180.2 million. Working capital excluding cash and short-term investments was $155.5 million. Borrowings comprised $2.4 million under revolving facilities and $15.5 million of long-term debt, including the current portion. Available credit lines and overdraft facilities totaled approximately $61.4 million. The company reported compliance with its financial covenants.
Material changes versus the prior comparable period
- Sales growth was led by materials processing, up 17.3%, particularly high- and mid-power lasers for cutting and welding and pulsed lasers for marking and engraving. Advanced applications grew 66.1%; medical sales declined 34.2%.
- Gross margin held at 54.2%. Lower internally manufactured component costs and product mix benefits were offset by reduced absorption of fixed manufacturing costs and higher inventory provisions, which rose to $8.2 million from $6.1 million.
- R&D expense increased 23.5% to $31.4 million; management said investment would continue. The reported foreign-exchange result shifted from a $2.9 million gain to a $1.4 million loss.
- Cash increased substantially, reflecting $167.9 million in net proceeds from a March 2012 share offering and $175.3 million of operating cash flow. Uses included $68.2 million of capital expenditures, a $55.4 million repurchase of the Russian subsidiary minority interest and a $33.4 million special dividend ($0.65 per share).
- IPG acquired the working capital and long-term assets of laser-systems business JP Sercel Associates for $11.6 million net of acquired cash; the acquisition did not materially affect 2012 results.
Outlook, commentary and risks
- Management expects existing cash, operating cash flows and credit lines to cover liquidity and capital needs for the foreseeable future. It projected 2013 capital expenditures of approximately $60–$70 million, excluding acquisitions.
- Year-end backlog was approximately $203 million, versus $207 million a year earlier; management anticipated shipping a substantial majority during 2013. Orders are generally cancelable without substantial penalties, and backlog is not necessarily indicative of future sales.
- Management expects increased aggregate spending on sales and marketing, R&D and infrastructure to support growth. It provided no specific revenue or earnings guidance in the supplied filing text.
- Operating cash flow in Q1 2013 was expected to be reduced by German corporate tax payments of more than $30 million, primarily relating to fiscal 2011.
- Key risks include cyclical customer capital spending and heavy reliance on materials processing; exposure to China and Russia, foreign exchange and export licensing; rising competition and selling-price pressure; substantial fixed manufacturing costs and inventory-obsolescence risk; dependence on key personnel and suppliers; and intellectual-property claims. The top five customers accounted for 16% of sales; the largest accounted for 7%.
- The filing reports no legal proceeding then expected by management to have a material effect on the financial statements. Deloitte issued unqualified opinions on the financial statements and internal control over financial reporting.
Important facts for investors to verify
- Whether materials-processing demand, especially in China, and adoption of fiber lasers sustain sales growth.
- Whether backlog converts to shipments, given cancelable orders and the declining firm-date portion of backlog.
- Whether margins withstand pricing pressure, capacity expansion, inventory provisions and changes in product mix.
- Whether projected 2013 capital spending and the German tax payment affect cash generation as expected.
- The terms and performance-based contingent consideration associated with the JPSA acquisition, including possible additional payments.
- Current debt, credit-facility availability, covenant headroom and the effect of currency movements on reported results.